CIK 0001999480 · Pharmaceutical Preparations (SIC 2834) · NYSE · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | |
|---|---|---|
| Net income (USD) | -63.2 M | -36.3 M |
| Diluted EPS (USD/shares) | -2.19 | -9.73 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-05 | 4 | FORM 4 | 2026-10-02 |
| 2026-10-01 | 4 | FORM 4 | 2026-09-29 |
| 2026-09-29 | 144 | 144 | |
| 2026-08-27 | 8-K | 8-K items 5.02,9.01 | 2026-08-26 |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-12 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-12 | 8-K | 8-K items 2.02,9.01 | 2026-08-12 |
| 2026-07-27 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-07-20 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-07-14 | 8-K | FORM 8-K items 1.01,9.01 | 2026-07-13 |
| 2026-07-14 | 424B5 | 424B5 | |
| 2026-07-13 | 8-K | FORM 8-K items 2.02,8.01 | 2026-07-13 |
| 2026-05-29 | 4 | FORM 4 | 2026-05-27 |
| 2026-05-29 | 3 | FORM 3 | 2026-05-27 |
| 2026-05-28 | 8-K | 8-K items 5.02 | 2026-05-27 |
| 2026-05-15 | 4 | FORM 4 | 2026-05-14 |
| 2026-05-15 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-05-15 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-05-15 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-05-15 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-05-14 | 4 | FORM 4 | 2026-05-12 |
| 2026-05-14 | 4 | FORM 4 | 2026-05-12 |
| 2026-05-14 | 4 | FORM 4 | 2026-05-12 |
Forms on file (last 1,000): 4 55, 8-K 30, SCHEDULE 13G/A 18, 3 15, CORRESP 9, 10-Q 8, SCHEDULE 13G 8, SC 13G 7. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=ANRO (0.002 USD), /gw/filings/filings?ticker=ANRO&form=8-K, /gw/filings/facts?ticker=ANRO&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange